Comments

Cytokinetics Stock Price, Quotes and Forecasts

Q: What sector and industry does Cytokinetics (CYTK) operate in?

Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CYTKNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Cytokinetics (CYTK) Forecast

News Earnings Cytokinetics (CYTK) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Cytokinetics Stock Price, Quotes and Forecasts | NASDAQ:CYTK | Benzinga

Explore Cytokinetics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CYTK.

Open	$34.72
Close	-
Volume / Avg.	715.91K / 2.06M
Day Range	$32.84 - $34.72
52 Wk Range	29.31 - 61.38
Market Cap	$4.05B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	15.84%
Days to Cover	8.46

Recent News

FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months

FDA extended the aficamten decision deadline to Dec. 26 after classifying the REMS submission as a major amendment to the NDA review.

Vandana Singh

Block, Atlassian, Apple, Roku, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Avi Kapoor

This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$34.72
Close	-
Volume / Avg.	715.91K / 2.06M
Day Range	$32.84 - $34.72
52 Wk Range	29.31 - 61.38
Market Cap	$4.05B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	15.84%
Days to Cover	8.46

About Cytokinetics Inc

Sector

Health Care

Industry

Biotechnology

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and co...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cytokinetics (CYTK) stock?

You can purchase shares of Cytokinetics (NASDAQ:CYTK) through any online brokerage.

View our list of the best stock brokerages

Who are Cytokinetics (CYTK) competitors?

Other companies in Cytokinetics’s space includes: Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sarepta Therapeutics (NASDAQ:SRPT), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).

What is the forecast, or price target, for Cytokinetics (CYTK) stock?

Cytokinetics has a consensus price target of $74.55.

What is the current price for Cytokinetics (CYTK)?

The stock price for Cytokinetics (NASDAQ: CYTK) is $33.88 last updated June 16, 2025 at 12:04 PM EDT.

Does Cytokinetics (CYTK) pay a dividend?

There are no upcoming dividends for Cytokinetics.

When is Cytokinetics (NASDAQ:CYTK) reporting earnings?

Cytokinetics’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Cytokinetics (CYTK) going to split?

There is no upcoming split for Cytokinetics.

What sector and industry does Cytokinetics (CYTK) operate in?

Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.